Together, these results show that in an established prostate cancer tumor xenograft, expression of NEP by injection with AdNEP together with systemic paclitaxel results in an increase in PTEN protein, a decrease in activated Akt, an increase in cell death and inhibition of tumor growth. This evidence concerns the gene AKT1 and Familial prostate cancer.